Cargando…

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer

BACKGROUND: Peritoneal carcinomatosis in ovarian cancer is frequent and generally associated with higher stage and poorer outcome. The clinical features of peritoneal carcinomatosis are diverse and their relevance for surgical and long-term outcome remains unclear. We conducted this prospective stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasser, Sara, Babayeva, Aygun, Braicu, Ioana, Richter, Rolf, Bilir, Esra, Chekerov, Radoslav, Muallem, Mustafa-Zelal, Pietzner, Klaus, Inci, Melissa-Guelhan, Sehouli, Jalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811584/
https://www.ncbi.nlm.nih.gov/pubmed/36620574
http://dx.doi.org/10.3389/fonc.2022.1014073
_version_ 1784863559270793216
author Nasser, Sara
Babayeva, Aygun
Braicu, Ioana
Richter, Rolf
Bilir, Esra
Chekerov, Radoslav
Muallem, Mustafa-Zelal
Pietzner, Klaus
Inci, Melissa-Guelhan
Sehouli, Jalid
author_facet Nasser, Sara
Babayeva, Aygun
Braicu, Ioana
Richter, Rolf
Bilir, Esra
Chekerov, Radoslav
Muallem, Mustafa-Zelal
Pietzner, Klaus
Inci, Melissa-Guelhan
Sehouli, Jalid
author_sort Nasser, Sara
collection PubMed
description BACKGROUND: Peritoneal carcinomatosis in ovarian cancer is frequent and generally associated with higher stage and poorer outcome. The clinical features of peritoneal carcinomatosis are diverse and their relevance for surgical and long-term outcome remains unclear. We conducted this prospective study to describe intraoperatively the different features of peritoneal carcinomatosis(PC) and correlate them with clinicopathological features, progression-free(PFS) and overall survival (OS),. METHODS: We performed a systematic analysis of all patients with documented intraoperative PC and a primary diagnosis of epithelial ovarian, tubal, or peritoneal cancer from January 2001 to September 2018. All data were evaluated by using the systematic tumor bank tool. Specific PC features included texture(soft-hard), consistency(coarse-fine or both), wet vs dry(PC with ascites vs. PC without ascites), and localization(diffuse-local). PC characteristics were then evaluated for correlation with age, FIGO-stage, histology, lymph-node involvement, grade, and presence of residual tumor at primary surgery. Moreover, the influence of PC characteristics on OS and PFS was analyzed. RESULTS: A total of 1686 patients with PC and primary epithelial ovarian cancer were included. Majority of the patients were characterized by diffuse PC(73.9%). The majority of peritoneal nodules were fine in texture (55.3%) and hard in consistency (87.4%). Moreover, 27.6% of patients had dry PC. Diffuse PC localization was significantly associated with higher FIGO-stage (p<0.001), high-grade (p=0.003) and serous tumors (p=0.006) as well as residual tumor as compared to local PC (p<0.001). Wet PC also significantly correlated with diffuse localization (p <0.001) and residual tumor as compared to dry PC (p<0.001). Coarse PC was significantly associated with residual tumor as compared to fine PC (p=0.044). All other PC features didn´t correlate with clinicopathological features. As for survival outcomes, diffuse peritoneal localization (p<0.001), wet PC (p<0.001), and additional lymph node involvement (p<0.001) were associated with lower OS and PFS rates. Other PC features did not significantly impact survival. CONCLUSION: Diffuse localization of peritoneal carcinomatosis was significant predictor of recurrence. Lower OS and PFS were associated with diffuse peritoneal localization, wet PC, and additional lymph node involvement. Further prospective trials are warranted with the inclusion of translational research aspects to better understand the different peritoneal carcinomatosis patterns.
format Online
Article
Text
id pubmed-9811584
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98115842023-01-05 Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer Nasser, Sara Babayeva, Aygun Braicu, Ioana Richter, Rolf Bilir, Esra Chekerov, Radoslav Muallem, Mustafa-Zelal Pietzner, Klaus Inci, Melissa-Guelhan Sehouli, Jalid Front Oncol Oncology BACKGROUND: Peritoneal carcinomatosis in ovarian cancer is frequent and generally associated with higher stage and poorer outcome. The clinical features of peritoneal carcinomatosis are diverse and their relevance for surgical and long-term outcome remains unclear. We conducted this prospective study to describe intraoperatively the different features of peritoneal carcinomatosis(PC) and correlate them with clinicopathological features, progression-free(PFS) and overall survival (OS),. METHODS: We performed a systematic analysis of all patients with documented intraoperative PC and a primary diagnosis of epithelial ovarian, tubal, or peritoneal cancer from January 2001 to September 2018. All data were evaluated by using the systematic tumor bank tool. Specific PC features included texture(soft-hard), consistency(coarse-fine or both), wet vs dry(PC with ascites vs. PC without ascites), and localization(diffuse-local). PC characteristics were then evaluated for correlation with age, FIGO-stage, histology, lymph-node involvement, grade, and presence of residual tumor at primary surgery. Moreover, the influence of PC characteristics on OS and PFS was analyzed. RESULTS: A total of 1686 patients with PC and primary epithelial ovarian cancer were included. Majority of the patients were characterized by diffuse PC(73.9%). The majority of peritoneal nodules were fine in texture (55.3%) and hard in consistency (87.4%). Moreover, 27.6% of patients had dry PC. Diffuse PC localization was significantly associated with higher FIGO-stage (p<0.001), high-grade (p=0.003) and serous tumors (p=0.006) as well as residual tumor as compared to local PC (p<0.001). Wet PC also significantly correlated with diffuse localization (p <0.001) and residual tumor as compared to dry PC (p<0.001). Coarse PC was significantly associated with residual tumor as compared to fine PC (p=0.044). All other PC features didn´t correlate with clinicopathological features. As for survival outcomes, diffuse peritoneal localization (p<0.001), wet PC (p<0.001), and additional lymph node involvement (p<0.001) were associated with lower OS and PFS rates. Other PC features did not significantly impact survival. CONCLUSION: Diffuse localization of peritoneal carcinomatosis was significant predictor of recurrence. Lower OS and PFS were associated with diffuse peritoneal localization, wet PC, and additional lymph node involvement. Further prospective trials are warranted with the inclusion of translational research aspects to better understand the different peritoneal carcinomatosis patterns. Frontiers Media S.A. 2022-12-21 /pmc/articles/PMC9811584/ /pubmed/36620574 http://dx.doi.org/10.3389/fonc.2022.1014073 Text en Copyright © 2022 Nasser, Babayeva, Braicu, Richter, Bilir, Chekerov, Muallem, Pietzner, Inci and Sehouli https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Nasser, Sara
Babayeva, Aygun
Braicu, Ioana
Richter, Rolf
Bilir, Esra
Chekerov, Radoslav
Muallem, Mustafa-Zelal
Pietzner, Klaus
Inci, Melissa-Guelhan
Sehouli, Jalid
Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
title Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
title_full Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
title_fullStr Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
title_full_unstemmed Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
title_short Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
title_sort can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? analysis of 1686 patients of the tumor bank ovarian cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811584/
https://www.ncbi.nlm.nih.gov/pubmed/36620574
http://dx.doi.org/10.3389/fonc.2022.1014073
work_keys_str_mv AT nassersara canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT babayevaaygun canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT braicuioana canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT richterrolf canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT biliresra canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT chekerovradoslav canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT muallemmustafazelal canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT pietznerklaus canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT incimelissaguelhan canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer
AT sehoulijalid canamorphologicaldescriptionoftheperitonealcarcinomatosisinadvancedovariancanceraddprognosticinformationanalysisof1686patientsofthetumorbankovariancancer